| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Nucleotrace has developed the first product-integrated supply chain monitoring and anti-counterfeiting technology for consumable products. Information such as the batch number, expiry date and manufacturing facility are encoded into fragments of DNA which are incorporated into the product as a non-toxic molecular fingerprint. Nucleotrace technology has the capacity to significantly reduce drug counterfeiting which is responsible for one million deaths and costs the pharmaceuticals industry $100 billion each year. |
| Category: | Defence, Health & biotech |
| URL: | http://nucleo-trace.com/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2016 |
| Address: | Inspire9, 41 Stewart St. |
| State: | Victoria |
| Overseas Operations: | No |
| X: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/nucleotrace |
| Founders: | |
| Awards won: | |

